Hyaluronan metabolism in remodeling extracellular matrix: probes for imaging and therapy of breast cancer.
Clinical and experimental evidence increasingly support the concept of cancer as a disease that emulates a component of wound healing, in particular abnormal stromal extracellular matrix remodeling. Here we review the biology and function of one remodeling process, hyaluronan (HA) metabolism, which is essential for wound resolution but closely linked to breast cancer (BCA) progression. Components of the HA metabolic cycle (HAS2, SPAM1 and HA receptors CD44, RHAMM/HMMR and TLR2) are discussed in terms of their known functions in wound healing and in breast cancer progression. Finally, we discuss recent advances in the use of HA-based platforms for developing nanoprobes to image areas of active HA metabolism and for therapeutics in breast cancer.
Life Sciences Division, Lawrence Berkeley National Laboratories, Berkeley, CA, USA. mveiseh@lbl.gov
M
M
Veiseh
E A
EA
Turley
D000818:Animals; D001943:Breast Neoplasms / Q000175:diagnosis / Q000378:metabolism* / Q000473:pathology / Q000628:therapy*; D016503:Drug Delivery Systems / Q000379:methods; D005109:Extracellular Matrix / Q000378:metabolism*; D005260:Female; D006801:Humans; D006820:Hyaluronic Acid / Q000378:metabolism*; D057054:Molecular Imaging / Q000379:methods
D006820:Hyaluronic Acid